Rise Therapeutics is developing targeted immunological-based biologics using a unique and proprietary oral delivery platform. The company develops unique, first-in-class immune modulatory drugs for the treatment of inflammation, autoimmunity and cancer.
Location: United States, Maryland, Rockville
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | TEDCO | tedcomd.co... |
Mentions in press and media 1
| Date | Title | Description |
| 15.07.2024 | First Type 1 Diabetes Patient Enrolled in Rise Therapeutics' Latest Clinical Trial | ROCKVILLE, Md., July 15, 2024 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it has enrolled its first patient in its R-5280 placebo controll... |